Milnubes / Curiosity, with sourcesBotany · Culture · Science
milnubes.
Milnubes/Encyclopedia/10-OH-HHC
Cannabinoid atlas / Reference entry
10-OH-HHC
Semisynthetic & derivatives

10-Hydroxyhexahydrocannabinol

The number in 10-OH-HHC indicates a chemical position, not a superior generation of HHC. Identity documentation exists, but a commercial name alone does not establish composition, benefits or a known profile of human effects.

Documentary review: Milnubes editorial desk · assisted by AI
A gloved hand adjusts a sample under a white microscope.
Stock photograph providing context for this entry. It does not document a trial, participant, identified product or 10-OH-HHC result.
Evidence map

Identity / very sparse data. This label summarises the type of data; it is neither a recommendation to use nor a safety rating.

How we read studies and personal accounts ↗

Identity

It denotes HHC hydroxylated at position 10. It is not equivalent to 9-OH-HHC, 11-OH-HHC or HHC-O acetate. Position and spatial arrangement need specifying for rigorous identification.

Source · Minor oxygenated cannabinoids from high potency Cannabis sativa L.Source · European Drug Report 2025: Trends and Developments

Terms associated with this entry: 10-hydroxyhexahydrocannabinol, 10-hidroxi-HHC.

Two dates, two questions

A 2015 botanical study described 10α-hydroxyhexahydrocannabinol among compounds isolated from cannabis. The 2025 European report records a 10-OH-HHC notification dated 17 December 2024. Identifying a compound in research and notifying it through market surveillance are different events.

Source · Minor oxygenated cannabinoids from high potency Cannabis sativa L.Source · European Drug Report 2025: Trends and Developments

The word ‘natural’ does not settle the research

A finding in plant material does not verify the origin of every later product. Nor does it demonstrate that a commercial mixture reproduces the studied substance. What each sample actually contains remains the relevant question.

Source · Minor oxygenated cannabinoids from high potency Cannabis sativa L.

What has been studied

No established clinical benefit

The consulted sources provide no demonstrated therapeutic benefits in people for 10-OH-HHC.

Source · Minor oxygenated cannabinoids from high potency Cannabis sativa L.Source · European Drug Report 2025: Trends and Developments

Risks and gaps

Identity documentation does not establish human safety; substance-specific clinical data remain insufficient.

Source · Minor oxygenated cannabinoids from high potency Cannabis sativa L.Source · European Drug Report 2025: Trends and Developments

Documented forms

A molecule and a product are different things. Read about flowers, resins, oils, creams, capsules and vaping.

Experiences

We have not included a verifiable individual account in this review. We do not fill that gap with commercial stories or invented experiences.

Conclusion

A short profile with visible gaps is preferable to filling the name with effects that remain unproven.

Legal context

Read the Spain note and official sources. Absence from a cited list does not establish that a product is lawful.

Sources

  1. Minor oxygenated cannabinoids from high potency Cannabis sativa L. · Laboratory study
  2. European Drug Report 2025: Trends and Developments · Official body

Source review: 2026-11-02. No external clinical review. Corrections: info@milnubes.com.